| Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. | Pharmacol Ther | 1998 Jul | 9719345 |
| Mutagenic specificity of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in Escherichia coli using the yeast URA3 gene as a target. | Carcinogenesis | 1998 Feb | 9498281 |
| Quinoline antimalarials: mechanisms of action and resistance. | Int J Parasitol | 1997 Feb | 9088993 |
| Antimutagenic effect of methanolic extracts from peanut hulls. | Biosci Biotechnol Biochem | 1996 Oct | 8987671 |
| Protective effect of N-acetylcysteine against heterocyclic amine-induced cardiotoxicity in cultured myocytes and in rats. | Food Chem Toxicol | 1995 Aug | 7672737 |
| Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). | FEBS Lett | 1994 Sep 19 | 7925942 |
| Inhibition by anti-malarial drugs of haemoglobin denaturation and iron release inacidified red blood cell lysates--a possible mechanism of their anti-malarialeffect? | Parasitology | 1994 May | 8008450 |
| Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. | Cancer Res | 1994 Jul 1 | 8012961 |
| Cardiotoxicity of heterocyclic amine food mutagens in cultured myocytes and in rats. | Toxicol Appl Pharmacol | 1994 Feb | 8122265 |
| Preparation and taste of certain glycosides of flavanones and ofdihydrochalcones. | Biosci Biotechnol Biochem | 1994 Aug | 7765281 |